Clozapine-induced neuroleptic malignant syndrome: an interaction between dopaminergic and purinergic systems?
Authors:
- A. L. WolfAWA. L. Wolf
- M. I. LobatoMLM. I. Lobato
- 1 May 1999
- journal article
- other
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 13 (3) , 318-319
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Involvement of Adenosine A2A Receptors in the Induction of C-Fos Expression by Clozapine and HaloperidolNeuropsychopharmacology, 1999
- The role of α2‐adrenoceptor antagonism in the anti‐cataleptic properties of the atypical neuroleptic agent, clozapine, in the ratBritish Journal of Pharmacology, 1998
- Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia1Published on the World Wide Web on 12 January 1998.1Brain Research Reviews, 1998
- Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsMolecular Psychiatry, 1998
- A new framework for investigating antipsychotic action in humans: lessons from PET imaging.Molecular Psychiatry, 1998
- Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive DyskinesiaJournal of Neurochemistry, 1995
- Clozapine-Induced Neuroleptic Malignant SyndromeJournal of Clinical Psychopharmacology, 1995
- Neuroleptic Malignant Syndrome Associated with Clozapine TreatmentAnnals of Clinical Psychiatry, 1995
- Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?The Journal of Neuropsychiatry and Clinical Neurosciences, 1995
- Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitroEuropean Journal of Pharmacology, 1984